Shanghai Pharmaceuticals Holding Co.,Ltd.’s Net Profit Dropped 17.2% in First Three Quarters of 2023

Shanghai Pharmaceuticals Holding Co.,Ltd. (上海医药集团股份有限公司) (601607.SH) reported a net profit of 5 billion yuan in the first three quarters of 2023, down 17.2% year-on-year.

Meanwhile, the company posted 197.5 billion yuan in revenue, up 13.1% year-on-year.

At the end of the reporting period, it had 213.1 billion yuan in total assets and 133 billion yuan in total liabilities, with a liability-to-asset ratio of 62.4%.